查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511940

獸用整形外科藥物市場規模、佔有率和趨勢分析報告：按產品類型、動物類型、應用、給藥途徑、最終用途、地區和細分市場預測，2024-2030年

Veterinary Orthopedic Medicines Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Application, By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 183 Pages | 商品交期: 2-10個工作天內

價格

整形外科市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球獸用整形外科藥物市場規模將達28.7億美元，2024年至2030年複合年成長率為8.6%。再生醫學的出現、獸醫學中擴大採用黏性補充以及寵物保險的快速增加是預計推動市場成長的一些關鍵因素。推動市場成長的其他因素包括獸醫學的進步。根據勃林格殷格翰和美國動物醫院協會 (AAHA) 進行的一項研究，五分之一的狗（即所有狗品種的 20%）在其一生中會經歷某種類型的關節問題。大多數動物因發育性整形外科疾病（DOD）而患有骨關節炎（OA），某些犬種比其他犬種更容易出現關節畸形。

獸醫再生醫學旨在恢復患病或受損細胞和組織的正常功能，包括基於細胞的療法等各種方法。間質基質細胞（MSC）、富血小板血漿（PRP）和自體血清製劑的使用在這個領域中很突出。這些治療方法目前用於治療狗、馬和貓等動物的肌腱、韌帶和關節/軟骨。這些治療主要以研究為基礎，更具體的臨床報告正在進行中。無論目前的用途如何，這一獸醫分支都顯示出有效治療和管理獸醫疾病的希望。

許多寵物飼主選擇寵物保險來照顧寵物的健康。根據《今日美國》 2024 年 2 月的一篇報導，大約 26% 的受訪美國人表示，他們每月在狗身上花費 51 至 100 美元。另一方面，有些寵物保險公司承保一定數量的處方藥。 Fetch Pet 藥物保險是為疾病和意外提供單一計劃的保險計劃之一。該計劃承保承保病症的所有處方藥，包括先天性和整形外科病症等慢性病。根據北美寵物健康保險協會（NAPHIA）統計，截至2023年，美國已購買價值約32億美元的寵物保險，到2022年終，美國將有約480萬隻寵物投保。此外，《富比士》估計，到 2023 年，因疾病或骨折等問題前往獸醫院緊急就診的費用可能約為 1,000 美元。

這是 1,000 美元。因此，寵物保險是彌補意外醫療費用的必要工具。

目前的再生療法如MSC和PRP屬於藥物類別。因此，FDA 將它們歸入「細胞產品」類別下進行監管。然而，迄今為止，這些治療方法均未獲得 FDA核准，且它們目前的使用屬於 FDA 的臨床實驗豁免範圍。此外，技術進步透過引入創新的治療方法和程序徹底改變了獸醫整形外科醫學。先進的診斷影像、基因編輯和幹細胞治療等新技術可以對動物健康進行更精確、更有效的干涉。這些創新提高了獸醫的診斷和治療能力，並為以前難以治療的病症提供了先進的解決方案。

整形外科骨科市場報告亮點

  • 製藥領域在 2023 年以 46.5% 的佔有率佔據市場主導地位，因為 NSAIDS 和類固醇等產品經常用於治療獸醫整形外科併發症。
  • 由於犬類骨關節炎的高盛行率、高市場採用率以及犬類運動傷害數量的增加，預計犬類市場在預測期內將以最快的複合年成長率成長。
  • 2023年OA領域佔最大市場佔有率。
  • 然而，關節發炎/疼痛部分預計在預測期內將呈現最快的成長。
  • 由於 OA 盛行率不斷上升、獸醫醫療基礎設施設備齊全、政府對優質獸醫醫療保健的支持以及美國寵物擁有量的增加，北美在全球獸醫整形外科市場中佔據主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章整形外科藥品市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 整形外科骨科市場分析工具
    • 波特的分析
    • PESTEL分析

第4章整形外科骨科市場：產品評估與趨勢分析

  • 2023 年和 2030 年按動物類型分類的市場佔有率佔有率
  • 細分儀表板
  • 整形外科骨科市場：產品展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 生物製藥
  • 黏性補充品
  • 藥品

第5章整形外科藥品市場：依動物類型估計及趨勢分析

  • 2023 年和 2030 年按動物類型分類的市場佔有率佔有率
  • 細分儀表板
  • 整形外科骨科市場：依動物種類分類的前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 狗
  • 馬
  • 其他

第6章整形外科藥品市場：應用預估及趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 整形外科骨科市場：應用前景
  • 骨關節炎
  • 骨關節炎（DJD）
  • 其他用途

第7章整形外科藥品市場：給藥途徑預估及趨勢分析

  • 2023 年及 2030 年給藥途徑市場佔有率
  • 細分儀表板
  • 整形外科骨科市場：給藥途徑展望
  • 口服
  • 可注射的
  • 其他

第8章整形外科骨科市場：最終用途估計和趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 整形外科市場：最終用戶展望
  • 動物醫院
  • 獸醫診所
  • 其他

第9章整形外科骨科市場：區域估計和趨勢分析

  • 2023年及2030年按地區分類的整形外科骨科市場佔有率
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司市場佔有率分析
  • 企業熱力圖分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • Zoetis Inc.
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent, Inc.
    • Merck Animal Health（Merck &Co. Inc）
    • Vetoquinol SA
    • Ceva Sante Animale
    • Virbac
    • Biogenesis Bago
    • Ardent Animal Health LLC.
    • Bioiberica SAU
    • PetVivo Holdings, Inc.（Spryng）
    • Contipro AS
    • VetStem, Inc.
    • Enso Discoveries
    • Contura Vet US
    • T-Cyte Therepeutics
    • MEDREGO LLC
    • Bimeda US
    • Hyalogic
    • Hester Biosciences
Product Code: GVR-4-68040-167-6

Veterinary Orthopedic Medicines Market Growth & Trends:

The global veterinary orthopedic medicines market size is expected to reach USD 2.87 billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The emergence of regenerative medicine, the rise in adoption of viscosupplements in veterinary medicine, and the surge in uptake of pet insurance are some of the major factors expected to propel market growth. Other factors fueling market growth include advancements in veterinary medicine. According to a study conducted by Boehringer Ingelheim and the American Animal Hospital Association (AAHA), 1 in 5 five dogs, i.e., 20% of all dogs, experience some kind of joint issue in their lifetime. A majority of animals suffer from Osteoarthritis (OA) due to Developmental Orthopedic Diseases (DODs), with certain breeds more prone to malformed joints than others.

Regenerative medicine in veterinary medicine aims to restore normal function of diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of Mesenchymal Stromal Cells (MSCs), Platelet-rich Plasma (PRP), and autologous serum products is prominent in this field. Currently, these therapies are used in the treatment of tendon, ligament, and joint/cartilage in animals like dogs, horses, & cats. These treatments are primarily research-based, and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine is showing promise for effective treatment & management of veterinary diseases.

Most pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article by USA Today, around 26% of the Americans surveyed stated they spend between USD 51 and USD 100 a month on their dogs. On the other hand, several pet insurance companies cover a certain amount of prescription medication. Fetch Pet medication coverage is one of the insurance plans that offers a single plan for illnesses and accidents. The plan covers all prescription drugs for covered conditions, including congenital and chronic ailments like orthopedic problems. According to the North American Pet Health Insurance Association (NAPHIA), as of 2023, there were pet insurance policies worth around USD 3.2 billion in the U.S. Comparably, there were around 4.8 million insured pets in the U.S. at the end of 2022, which was a 22% rise since 2021. Moreover, according to Forbes estimates, in 2023, a veterinary emergency visit for challenges, such as ailments or a broken bone, might cost around

USD 1,000. Hence, pet insurance is a necessary tool for covering unforeseen medical expenses.

Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Hence, the FDA regulates them under the category "Cell-based Products"; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. In addition, technological advancements revolutionized veterinary orthopedic medicine by introducing innovative treatments and procedures. Novel technologies, such as advanced imaging, gene editing, and stem cell therapies, enable more precise & effective interventions in animal health. These technological breakthroughs enhance the diagnostic and treatment capabilities of veterinarians, providing advanced solutions for conditions that were previously challenging to address.

Veterinary Orthopedic Medicines Market Report Highlights:

  • The pharmaceuticals segment dominated the market with a 46.5% share in 2023 due to the high adoption of products, such as NSAIDS, steroids, etc., in the treatment of veterinary orthopedic complications.
  • The canine segment is expected to grow at the fastest CAGR over the forecast period due to the high prevalence of OA in dogs, the high market adoption, and the rise in sports injuries among dogs.
  • The OA segment held the largest market share in 2023.
  • However, the joint inflammation/pain segment is anticipated to witness the fastest growth over the forecast period.
  • North America dominated the global veterinary orthopedic medicines market due to the increasing prevalence of OA, well-equipped veterinary care infrastructure, government support for quality animal care, and increasing pet adoption in the U.S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Type
    • 1.2.3. Application
    • 1.2.4. Route of administration
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Animal Type
    • 2.2.3. Application
    • 2.2.4. Route of administration
    • 2.2.5. End Use
    • 2.2.6. Regional scope
  • 2.3. Competitive Insights

Chapter 3. Veterinary Orthopedic Medicines Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of orthopedic problems
      • 3.2.1.2. Growing uptake of pet insurance
      • 3.2.1.3. Increase in ageing animal population
      • 3.2.1.4. Advancements in veterinary orthopedic medicines
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Shortage of veterinarians
      • 3.2.2.2. High treatment cost
  • 3.3. Veterinary Orthopedic Medicines Market Analysis Tools
    • 3.3.1. Porter's Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Veterinary Orthopedic Medicines Market: Product Estimates & Trend Analysis

  • 4.1. Animal Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Veterinary Orthopedic Medicines Market: Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Biologics
    • 4.5.1. Biologics Market, 2018 to 2030 (USD Million)
  • 4.6. Viscosupplements
    • 4.6.1. Viscosupplements Market, 2018 to 2030 (USD Million)
  • 4.7. Pharmaceuticals
    • 4.7.1. Pharmaceuticals Market, 2018 to 2030 (USD Million)

Chapter 5. Veterinary Orthopedic Medicines Market: Animal Type Estimates & Trend Analysis

  • 5.1. Animal Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Veterinary Orthopedic Medicines Market: Animal Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Canine
    • 5.5.1. Canine Market, 2018 to 2030 (USD Million)
  • 5.6. Equine
    • 5.6.1. Equine Market, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Veterinary Orthopedic Medicines Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Veterinary Orthopedic Medicines Market: Application Outlook
  • 6.4. Osteoarthritis
    • 6.4.1. Osteoarthritis Market, 2018 to 2030 (USD Million)
  • 6.5. Degenerative Joint Disease (DJD)
    • 6.5.1. Degenerative Joint Disease (DJD) Market, 2018 to 2030 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Other Applications Market, 2018 to 2030 (USD Million)

Chapter 7. Veterinary Orthopedic Medicines Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Route of Administration Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Veterinary Orthopedic Medicines Market: Route of Administration Outlook
  • 7.4. Oral
    • 7.4.1. Oral Market, 2018 to 2030 (USD Million)
  • 7.5. Injectable
    • 7.5.1. Injectable Market, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 8. Veterinary Orthopedic Medicines Market: End use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Veterinary Orthopedic Medicines Market: End user Outlook
  • 8.4. Veterinary Hospitals
    • 8.4.1. Veterinary Hospitals Market, 2018 to 2030 (USD Million)
  • 8.5. Veterinary Clinics
    • 8.5.1. Veterinary Clinics Market, 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 9. Veterinary Orthopedic Medicines Market: Regional Estimates & Trend Analysis

  • 9.1. Veterinary Orthopedic Medicines Market Share, By Region, 2023 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 9.3. Europe
    • 9.3.1. Europe Market Estimates and Forecasts, 2018 - 2030
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France Market Estimates and Forecasts, 2018 - 2030
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India Market Estimates and Forecasts, 2018 - 2030
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. South Korea Market Estimates and Forecasts, 2018 - 2030
  • 9.5. Latin America
    • 9.5.1. Latin America Market Estimates and Forecasts, 2018 - 2030
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Market Share Analysis
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Zoetis Inc.
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Boehringer Ingelheim
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Elanco Animal Health
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. American Regent, Inc.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. Merck Animal Health (Merck & Co. Inc)
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Vetoquinol S.A.
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Ceva Sante Animale
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Virbac
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Biogenesis Bago
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Ardent Animal Health LLC.
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Bioiberica S.A.U
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. PetVivo Holdings, Inc. (Spryng)
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Contipro A.S.
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments
    • 10.6.14. VetStem, Inc.
      • 10.6.14.1. Participant's Overview
      • 10.6.14.2. Financial Performance
      • 10.6.14.3. Product Benchmarking
      • 10.6.14.4. Recent Developments
    • 10.6.15. Enso Discoveries
      • 10.6.15.1. Participant's Overview
      • 10.6.15.2. Financial Performance
      • 10.6.15.3. Product Benchmarking
      • 10.6.15.4. Recent Developments
    • 10.6.16. Contura Vet US
      • 10.6.16.1. Participant's Overview
      • 10.6.16.2. Financial Performance
      • 10.6.16.3. Product Benchmarking
      • 10.6.16.4. Recent Developments
    • 10.6.17. T-Cyte Therepeutics
      • 10.6.17.1. Participant's Overview
      • 10.6.17.2. Financial Performance
      • 10.6.17.3. Product Benchmarking
      • 10.6.17.4. Recent Developments
    • 10.6.18. MEDREGO LLC
      • 10.6.18.1. Participant's Overview
      • 10.6.18.2. Financial Performance
      • 10.6.18.3. Product Benchmarking
      • 10.6.18.4. Recent Developments
    • 10.6.19. Bimeda U.S.
      • 10.6.19.1. Participant's Overview
      • 10.6.19.2. Financial Performance
      • 10.6.19.3. Product Benchmarking
      • 10.6.19.4. Recent Developments
    • 10.6.20. Hyalogic
      • 10.6.20.1. Participant's Overview
      • 10.6.20.2. Financial Performance
      • 10.6.20.3. Product Benchmarking
      • 10.6.20.4. Recent Developments
    • 10.6.21. Hester Biosciences
      • 10.6.21.1. Participant's Overview
      • 10.6.21.2. Financial Performance
      • 10.6.21.3. Product Benchmarking
      • 10.6.21.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 North America Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 6 North America Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 13 U.S. Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 20 Europe Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Europe Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 UK Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 27 UK Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 28 UK Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 UK Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Germany Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 35 France Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 France Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 37 France Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 38 France Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 France Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 40 Italy Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 Italy Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 42 Italy Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 43 Italy Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 Italy Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 45 Spain Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Spain Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 48 Spain Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Spain Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 52 Denmark Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 53 Denmark Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 Denmark Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 55 Sweden Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 57 Sweden Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 58 Sweden Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 Sweden Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 60 Norway Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 Norway Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 62 Norway Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 63 Norway Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Norway Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 71 China Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 China Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 73 China Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 74 China Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 China Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 76 Japan Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 Japan Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 78 Japan Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 79 Japan Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 Japan Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 81 India Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 India Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 83 India Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 84 India Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 India Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 86 Australia Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 Australia Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 88 Australia Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 89 Australia Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Australia Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 91 South Korea Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 South Korea Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 93 South Korea Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 94 South Korea Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 South Korea Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 96 Thailand Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Thailand Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 98 Thailand Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 99 Thailand Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 100 Thailand Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 101 Latin America Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 102 Latin America Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Latin America Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 104 Latin America Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 105 Latin America Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 106 Latin America Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 107 Brazil Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 108 Brazil Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 109 Brazil Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 110 Brazil Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 111 Brazil Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 112 Mexico Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 113 Mexico Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 114 Mexico Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 115 Mexico Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 116 Mexico Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 117 Argentina Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 Argentina Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 119 Argentina Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 120 Argentina Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 121 Argentina Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 122 MEA Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 123 MEA Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 124 MEA Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 125 MEA Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 126 MEA Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 127 MEA Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 128 South Africa Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 129 South Africa Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 130 South Africa Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 131 South Africa Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 132 South Africa Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 138 UAE Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 139 UAE Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 140 UAE Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 141 UAE Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 142 UAE Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 144 Kuwait Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 145 Kuwait Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Veterinary Orthopedic Medicines Market Segmentation
  • Fig. 2 Disease Epidemiology
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Veterinary Orthopedic Medicines - Market Size and Growth Prospects (USD Million)
  • Fig. 12 Veterinary Orthopedic Medicines Market: Industry Value Chain Analysis
  • Fig. 13 Veterinary Orthopedic Medicines Market: Market Dynamics
  • Fig. 14 Veterinary Orthopedic Medicines Market: PORTER's Analysis
  • Fig. 15 Veterinary Orthopedic Medicines Market: PESTEL Analysis
  • Fig. 16 Veterinary Orthopedic Medicines Market Share By Product, 2023 & 2030 (USD Million)
  • Fig. 17 Veterinary Orthopedic Medicines Market, By Product: Market Share, 2023 & 2030
  • Fig. 18 Biologics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Viscosupplements Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Pharmaceuticals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Veterinary Orthopedic Medicines Market Share By Animal type, 2023 & 2030 (USD Million)
  • Fig. 22 Veterinary Orthopedic Medicines Market, By Animal type: Market Share, 2023 & 2030
  • Fig. 23 Canine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Equine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 26 Veterinary Orthopedic Medicines Market Share By Application, 2023 & 2030 (USD Million)
  • Fig. 27 Veterinary Orthopedic Medicines Market, By Application: Market Share, 2023 & 2030
  • Fig. 28 Osteoarthritis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Degenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 31 Veterinary Orthopedic Medicines Market Share By Route of Administration, 2023 & 2030 (USD Million)
  • Fig. 32 Veterinary Orthopedic Medicines Market, By Route of Administration: Market Share, 2023 & 2030
  • Fig. 33 Oral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 Injectable Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Veterinary Orthopedic Medicines Market, by End User: Key Takeaways
  • Fig. 36 Veterinary Orthopedic Medicines Market, by End User: Market Share, 2023 & 2030
  • Fig. 37 Veterinary Hospitals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 Veterinary Clinics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 39 Other Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 40 Fig. 39 Veterinary Orthopedic Medicines Market Revenue, by Region, 2023 & 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 Regional Marketplace: Key Takeaways
  • Fig. 43 North America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
  • Fig. 48 Germany Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Veterinary Orthopedic Medicines Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 China Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 MEA Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 KSA Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 Kuwait Market Estimates and Forecasts, 2018 - 2030